Navamedic’s product Glucomed®/Flexove(TM) approved in EU by CHMP

Navamedic’s product Glucomed®/Flexove(TM) approved in EU by CHMP Navamedic has received notice that its glucosamine HCl product Glucomed®/Flexove(TM) has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP). The approval will be valid for all 25 EU/EEA countries in Navamedic’s application.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales UK: Comments needed on phytosterol application Lipofoods, has asked the UK Food Standards Agency's expert advisers on novel foods for an opinion on the ‘equivalence’ of a phytosterol ingredient to be used in various foods. UK: Comments needed on phytosterol application Lipofoods, has asked the UK Food Standards Agency's expert advisers on novel foods for an opinion on the ‘equivalence’ of a phytosterol ingredient to be used in various foods. UK: Comments needed on phytosterol application Lipofoods, has asked the UK Food Standards Agency's expert advisers on novel foods for an opinion on the ‘equivalence’ of a phytosterol ingredient to be used in various foods. UK: Comments needed on phytosterol application Lipofoods, has asked the UK Food Standards Agency's expert advisers on novel foods for an opinion on the ‘equivalence’ of a phytosterol ingredient to be used in various foods. UK: FSA Call for views on echium oil The UK Food Standards Agency has received an application to use refined echium oil as a novel food ingredient. UK: FSA Call for views on echium oil The UK Food Standards Agency has received an application to use refined echium oil as a novel food ingredient. UK: FSA Call for views on echium oil The UK Food Standards Agency has received an application to use refined echium oil as a novel food ingredient. UK: FSA Call for views on echium oil The UK Food Standards Agency has received an application to use refined echium oil as a novel food ingredient. UK: FSA Call for views on echium oil The UK Food Standards Agency has received an application to use refined echium oil as a novel food ingredient. UK: FSA Call for views on echium oil The UK Food Standards Agency has received an application to use refined echium oil as a novel food ingredient. UK: FSA Call for views on echium oil The UK Food Standards Agency has received an application to use refined echium oil as a novel food ingredient. UK: FSA Call for views on echium oil The UK Food Standards Agency has received an application to use refined echium oil as a novel food ingredient. FSA Receives Glucosamine Hydrochloride Application The Agency has received an application from Cargill to use glucosamine hydrochloride in a range of foods, including smoothies and sports drinks. FSA Receives Glucosamine Hydrochloride Application The Agency has received an application from Cargill to use glucosamine hydrochloride in a range of foods, including smoothies and sports drinks. FSA Receives Glucosamine Hydrochloride Application The Agency has received an application from Cargill to use glucosamine hydrochloride in a range of foods, including smoothies and sports drinks. FSA Receives Glucosamine Hydrochloride Application The Agency has received an application from Cargill to use glucosamine hydrochloride in a range of foods, including smoothies and sports drinks. FSA Receives Glucosamine Hydrochloride Application The Agency has received an application from Cargill to use glucosamine hydrochloride in a range of foods, including smoothies and sports drinks. FSA Receives Glucosamine Hydrochloride Application The Agency has received an application from Cargill to use glucosamine hydrochloride in a range of foods, including smoothies and sports drinks. FSA to Hold Vitamins and Minerals Stakeholder Meeting The Food Standards Agency is to hold a second meeting with stakeholders on its draft response to a European Commission (EC) discussion document on setting maximum levels for vitamins and minerals in foodstuffs, on 4 September 2006 at the Agency's London offices. FSA to Hold Vitamins and Minerals Stakeholder Meeting The Food Standards Agency is to hold a second meeting with stakeholders on its draft response to a European Commission (EC) discussion document on setting maximum levels for vitamins and minerals in foodstuffs, on 4 September 2006 at the Agency's London offices. FSA to Hold Vitamins and Minerals Stakeholder Meeting The Food Standards Agency is to hold a second meeting with stakeholders on its draft response to a European Commission (EC) discussion document on setting maximum levels for vitamins and minerals in foodstuffs, on 4 September 2006 at the Agency's London offices. FSA to Hold Vitamins and Minerals Stakeholder Meeting The Food Standards Agency is to hold a second meeting with stakeholders on its draft response to a European Commission (EC) discussion document on setting maximum levels for vitamins and minerals in foodstuffs, on 4 September 2006 at the Agency's London offices. FSA to Hold Vitamins and Minerals Stakeholder Meeting The Food Standards Agency is to hold a second meeting with stakeholders on its draft response to a European Commission (EC) discussion document on setting maximum levels for vitamins and minerals in foodstuffs, on 4 September 2006 at the Agency's London offices. FSA to Hold Vitamins and Minerals Stakeholder Meeting The Food Standards Agency is to hold a second meeting with stakeholders on its draft response to a European Commission (EC) discussion document on setting maximum levels for vitamins and minerals in foodstuffs, on 4 September 2006 at the Agency's London offices. FSA to Hold Vitamins and Minerals Stakeholder Meeting The Food Standards Agency is to hold a second meeting with stakeholders on its draft response to a European Commission (EC) discussion document on setting maximum levels for vitamins and minerals in foodstuffs, on 4 September 2006 at the Agency's London offices. UK: Comments wanted on phytosterol French company, DRT, has asked for a decision on its phytosterol ingredient, which is derived from tall oil pitch – a substance distilled from pine resin. UK: Comments wanted on phytosterol French company, DRT, has asked for a decision on its phytosterol ingredient, which is derived from tall oil pitch – a substance distilled from pine resin. UK: Comments wanted on phytosterol French company, DRT, has asked for a decision on its phytosterol ingredient, which is derived from tall oil pitch – a substance distilled from pine resin. UK: Comments wanted on phytosterol French company, DRT, has asked for a decision on its phytosterol ingredient, which is derived from tall oil pitch – a substance distilled from pine resin. UK: Comments wanted on phytosterol French company, DRT, has asked for a decision on its phytosterol ingredient, which is derived from tall oil pitch – a substance distilled from pine resin. TGA Approves EPAX’S Omega-3 Oils For Use In Australia’s Complementary Medicine Products Company announced that after 18 months of working closely with its Australian distributor Pathway International, it has been granted regulatory approval from Australia’s Therapeutic Goods Administration (TGA), allowing EPAX’s range of omega-3 oils to be used in complementary medicine products in Australia. TGA Approves EPAX’S Omega-3 Oils For Use In Australia’s Complementary Medicine Products Company announced that after 18 months of working closely with its Australian distributor Pathway International, it has been granted regulatory approval from Australia’s Therapeutic Goods Administration (TGA), allowing EPAX’s range of omega-3 oils to be used in complementary medicine products in Australia. TGA Approves EPAX’S Omega-3 Oils For Use In Australia’s Complementary Medicine Products Company announced that after 18 months of working closely with its Australian distributor Pathway International, it has been granted regulatory approval from Australia’s Therapeutic Goods Administration (TGA), allowing EPAX’s range of omega-3 oils to be used in complementary medicine products in Australia. TGA Approves EPAX’S Omega-3 Oils For Use In Australia’s Complementary Medicine Products Company announced that after 18 months of working closely with its Australian distributor Pathway International, it has been granted regulatory approval from Australia’s Therapeutic Goods Administration (TGA), allowing EPAX’s range of omega-3 oils to be used in complementary medicine products in Australia. TGA Approves EPAX’S Omega-3 Oils For Use In Australia’s Complementary Medicine Products Company announced that after 18 months of working closely with its Australian distributor Pathway International, it has been granted regulatory approval from Australia’s Therapeutic Goods Administration (TGA), allowing EPAX’s range of omega-3 oils to be used in complementary medicine products in Australia. Debate on EU vitamins and minerals picks up pace at EHPM/ERNA conference The quest to establish EU-wide agreement on maximum levels for vitamins and minerals took a step forward last week when more than 100 stakeholders convened in Brussels to debate the issue. Debate on EU vitamins and minerals picks up pace at EHPM/ERNA conference The quest to establish EU-wide agreement on maximum levels for vitamins and minerals took a step forward last week when more than 100 stakeholders convened in Brussels to debate the issue. Debate on EU vitamins and minerals picks up pace at EHPM/ERNA conference The quest to establish EU-wide agreement on maximum levels for vitamins and minerals took a step forward last week when more than 100 stakeholders convened in Brussels to debate the issue. Debate on EU vitamins and minerals picks up pace at EHPM/ERNA conference The quest to establish EU-wide agreement on maximum levels for vitamins and minerals took a step forward last week when more than 100 stakeholders convened in Brussels to debate the issue. IADSA Assesses Safety Levels For Bioactives the International Alliance of Dietary/Food Supplement Association (IADSA) has published “The Risk Assessment and Safety of Bioactive Substances in Food Supplements”, prepared by IADSA’s Scientific Group with the help of international experts. The report addresses the addition of non-nutrient bioactive substances to foods, detailing the methodology behind the risk assessment model used to develop upper safe levels for a number of bioactive substances including glucosamine, omega-3, coenzyme Q10 and lutein. IADSA Assesses Safety Levels For Bioactives the International Alliance of Dietary/Food Supplement Association (IADSA) has published “The Risk Assessment and Safety of Bioactive Substances in Food Supplements”, prepared by IADSA’s Scientific Group with the help of international experts. The report addresses the addition of non-nutrient bioactive substances to foods, detailing the methodology behind the risk assessment model used to develop upper safe levels for a number of bioactive substances including glucosamine, omega-3, coenzyme Q10 and lutein. IADSA Assesses Safety Levels For Bioactives the International Alliance of Dietary/Food Supplement Association (IADSA) has published “The Risk Assessment and Safety of Bioactive Substances in Food Supplements”, prepared by IADSA’s Scientific Group with the help of international experts. The report addresses the addition of non-nutrient bioactive substances to foods, detailing the methodology behind the risk assessment model used to develop upper safe levels for a number of bioactive substances including glucosamine, omega-3, coenzyme Q10 and lutein. IADSA Assesses Safety Levels For Bioactives the International Alliance of Dietary/Food Supplement Association (IADSA) has published “The Risk Assessment and Safety of Bioactive Substances in Food Supplements”, prepared by IADSA’s Scientific Group with the help of international experts. The report addresses the addition of non-nutrient bioactive substances to foods, detailing the methodology behind the risk assessment model used to develop upper safe levels for a number of bioactive substances including glucosamine, omega-3, coenzyme Q10 and lutein. IADSA Assesses Safety Levels For Bioactives the International Alliance of Dietary/Food Supplement Association (IADSA) has published “The Risk Assessment and Safety of Bioactive Substances in Food Supplements”, prepared by IADSA’s Scientific Group with the help of international experts. The report addresses the addition of non-nutrient bioactive substances to foods, detailing the methodology behind the risk assessment model used to develop upper safe levels for a number of bioactive substances including glucosamine, omega-3, coenzyme Q10 and lutein. Guide to EU functional food legislation launched in Japanese Belgium-based EAS has created a unique tool to assist the ongoing EU-Japan dialogue on functional food and food supplement legislation – a version of their EU regulations guide translated into Japanese. Guide to EU functional food legislation launched in Japanese Belgium-based EAS has created a unique tool to assist the ongoing EU-Japan dialogue on functional food and food supplement legislation – a version of their EU regulations guide translated into Japanese. Guide to EU functional food legislation launched in Japanese Belgium-based EAS has created a unique tool to assist the ongoing EU-Japan dialogue on functional food and food supplement legislation – a version of their EU regulations guide translated into Japanese. Guide to EU functional food legislation launched in Japanese Belgium-based EAS has created a unique tool to assist the ongoing EU-Japan dialogue on functional food and food supplement legislation – a version of their EU regulations guide translated into Japanese. Guide to EU functional food legislation launched in Japanese Belgium-based EAS has created a unique tool to assist the ongoing EU-Japan dialogue on functional food and food supplement legislation – a version of their EU regulations guide translated into Japanese. Guide to EU functional food legislation launched in Japanese Belgium-based EAS has created a unique tool to assist the ongoing EU-Japan dialogue on functional food and food supplement legislation – a version of their EU regulations guide translated into Japanese. Industry and NGOs remain divided on mandatory nutrition labelling A public consultation document “Labelling: competitiveness, consumer information and better regulation for the EU” initiated last year, show an acute difference of opinion between industry and consumer, health and animal welfare NGO’s, with viewpoints from governments fluctuating between the two. Industry and NGOs remain divided on mandatory nutrition labelling A public consultation document “Labelling: competitiveness, consumer information and better regulation for the EU” initiated last year, show an acute difference of opinion between industry and consumer, health and animal welfare NGO’s, with viewpoints from governments fluctuating between the two. Industry and NGOs remain divided on mandatory nutrition labelling A public consultation document “Labelling: competitiveness, consumer information and better regulation for the EU” initiated last year, show an acute difference of opinion between industry and consumer, health and animal welfare NGO’s, with viewpoints from governments fluctuating between the two. Industry and NGOs remain divided on mandatory nutrition labelling A public consultation document “Labelling: competitiveness, consumer information and better regulation for the EU” initiated last year, show an acute difference of opinion between industry and consumer, health and animal welfare NGO’s, with viewpoints from governments fluctuating between the two. Industry and NGOs remain divided on mandatory nutrition labelling A public consultation document “Labelling: competitiveness, consumer information and better regulation for the EU” initiated last year, show an acute difference of opinion between industry and consumer, health and animal welfare NGO’s, with viewpoints from governments fluctuating between the two. FSA: Call for comments on draft novel food opinions The Agency’s expert advisory committee on novel foods, the Advisory Committee on Novel Foods and Processes (ACNFP), is consulting on draft opinions on applications on the ‘substantial equivalence’ of two novel ingredients. Cyanotech Corporation has asked for its astaxanthin-rich extract, obtained from the dried algae biomass of Haematococcus pluvialis, to be approved as substantially equivalent to a H. pluvialis astaxanthin-rich algal meal, and Lipofoods has requested an opinion from the Agency on the equivalence of their phytosterol ingredient derived from soya with the phytosterol ingredient marketed by Archer Daniels Midland (ADM) and authorised in 2004. FSA: Call for comments on draft novel food opinions The Agency’s expert advisory committee on novel foods, the Advisory Committee on Novel Foods and Processes (ACNFP), is consulting on draft opinions on applications on the ‘substantial equivalence’ of two novel ingredients. Cyanotech Corporation has asked for its astaxanthin-rich extract, obtained from the dried algae biomass of Haematococcus pluvialis, to be approved as substantially equivalent to a H. pluvialis astaxanthin-rich algal meal, and Lipofoods has requested an opinion from the Agency on the equivalence of their phytosterol ingredient derived from soya with the phytosterol ingredient marketed by Archer Daniels Midland (ADM) and authorised in 2004. FSA: Call for comments on draft novel food opinions The Agency’s expert advisory committee on novel foods, the Advisory Committee on Novel Foods and Processes (ACNFP), is consulting on draft opinions on applications on the ‘substantial equivalence’ of two novel ingredients. Cyanotech Corporation has asked for its astaxanthin-rich extract, obtained from the dried algae biomass of Haematococcus pluvialis, to be approved as substantially equivalent to a H. pluvialis astaxanthin-rich algal meal, and Lipofoods has requested an opinion from the Agency on the equivalence of their phytosterol ingredient derived from soya with the phytosterol ingredient marketed by Archer Daniels Midland (ADM) and authorised in 2004. FSA: Call for comments on draft novel food opinions The Agency’s expert advisory committee on novel foods, the Advisory Committee on Novel Foods and Processes (ACNFP), is consulting on draft opinions on applications on the ‘substantial equivalence’ of two novel ingredients. Cyanotech Corporation has asked for its astaxanthin-rich extract, obtained from the dried algae biomass of Haematococcus pluvialis, to be approved as substantially equivalent to a H. pluvialis astaxanthin-rich algal meal, and Lipofoods has requested an opinion from the Agency on the equivalence of their phytosterol ingredient derived from soya with the phytosterol ingredient marketed by Archer Daniels Midland (ADM) and authorised in 2004. FSA: Call for comments on draft novel food opinions The Agency’s expert advisory committee on novel foods, the Advisory Committee on Novel Foods and Processes (ACNFP), is consulting on draft opinions on applications on the ‘substantial equivalence’ of two novel ingredients. Cyanotech Corporation has asked for its astaxanthin-rich extract, obtained from the dried algae biomass of Haematococcus pluvialis, to be approved as substantially equivalent to a H. pluvialis astaxanthin-rich algal meal, and Lipofoods has requested an opinion from the Agency on the equivalence of their phytosterol ingredient derived from soya with the phytosterol ingredient marketed by Archer Daniels Midland (ADM) and authorised in 2004. IADSA Fights to Keep Key Additives in Food Supplements Organization has pledged to continue fighting to retain key additives used in food supplements in the Codex ‘General Standard for Food Additives’ list this year. IADSA Fights to Keep Key Additives in Food Supplements Organization has pledged to continue fighting to retain key additives used in food supplements in the Codex ‘General Standard for Food Additives’ list this year. IADSA Fights to Keep Key Additives in Food Supplements Organization has pledged to continue fighting to retain key additives used in food supplements in the Codex ‘General Standard for Food Additives’ list this year. IADSA Fights to Keep Key Additives in Food Supplements Organization has pledged to continue fighting to retain key additives used in food supplements in the Codex ‘General Standard for Food Additives’ list this year. IADSA Fights to Keep Key Additives in Food Supplements Organization has pledged to continue fighting to retain key additives used in food supplements in the Codex ‘General Standard for Food Additives’ list this year. IADSA Fights to Keep Key Additives in Food Supplements Organization has pledged to continue fighting to retain key additives used in food supplements in the Codex ‘General Standard for Food Additives’ list this year. UK: Agency seeks evidence of consumption of goji berries The Food Standards Agency has written to retailers, health food companies and other stakeholders asking for evidence of people eating goji berries within the European Union before May 1997. UK: Agency seeks evidence of consumption of goji berries The Food Standards Agency has written to retailers, health food companies and other stakeholders asking for evidence of people eating goji berries within the European Union before May 1997. UK: Agency seeks evidence of consumption of goji berries The Food Standards Agency has written to retailers, health food companies and other stakeholders asking for evidence of people eating goji berries within the European Union before May 1997. UK: Agency seeks evidence of consumption of goji berries The Food Standards Agency has written to retailers, health food companies and other stakeholders asking for evidence of people eating goji berries within the European Union before May 1997. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	Lysaker, Norway, 22 September 2006- Navamedic has received notice that its glucosamine HCl product Glucomed®/Flexove(TM) has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP). A formal approval is expected from a Standing Committee of the EU Commission in the next three months. The approval will be valid for all 25 EU/EEA countries in Navamedic’s application, and Navamedic is preparing for product launches in several new markets during 2007. The case was decided by majority vote in a regular meeting in the CHMP 18-21 September. A considerable majority of the CHMP members voted in favor of the approval. -This is a major breakthrough for us. We have already signed up a series of strong marketing and distribution partners covering 14 countries inside and outside EU/EEA, and are looking forward to start launching our product across Europe in the year to come. Given the efficacy, safety and quality profile of our glucosamine HCl product Glucomed®/Flexove(TM) we feel confident it will be a welcome therapeutic alternative for the large and growing patient group suffering from osteoarthritis, says CEO Øyvind W. Brekke in Navamedic ASA. -This decision provides Navamedic with an opportunity to become among the leading players in a large and growing market. Navamedic’s glucosamine HCl product Glucomed®/Flexove(TM) for symptom relief in patients with osteoarthritis was approved in Sweden last August. Using Sweden as a reference member state, Navamedic applied for approval in further 24 EU/EAA countries in October 2005, under the rules of Mutual Recognition Procedure (MRP). In January, 19 countries approved the product but due to negative reviews from five countries the application was further referred to arbitration in the Committee for Medicinal Products for Human Use (CHMP), which is a sub-committee of the European Medicines Agency. This disagreement has now been settled through the CHMP decision. The Opinion from the CHMP will be submitted to a Standing Committee of the EU Commission, which is expected to issue the formal approval within the coming three months. Only in exceptional cases will this differ from the Opinion of the CHMP. National Marketing Authorisations (including approval of product information and packaging in local languages) should be obtained within Q1 2007. -The product has already been launched in Sweden and Iceland. We have already requested national Marketing Authorisations in the countries which approved the product in January and will file in the rest of the countries as soon as possible. All in all we expect to get going with further launches from the second quarter 2007, says Brekke. The countries covered by the decision are Austria, Belgium, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, the Netherlands, Norway, Portugal, Poland, Slovakia, Spain, Sweden and United Kingdom. About Navamedic ASA: Navamedic is a Norwegian speciality pharmaceutical company focusing on the development and production of glucosamine HCl (hydrochloride) based medicines. Glucosamine is a generic active ingredient which relieves pain and improves function in patients with mild to moderate osteoarthritis. The product has a favourable safety profile. Osteoarthritis is a chronic disease which affects a large and growing share of the world’s population. Navamedic aims to become a leading company in the glucosamine industry, with a competitive advantage in proprietary production technology. The company’s products will be sold through a network of sales, marketing and distribution partners.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software